A stilbenol that is stilbene in which the phenyl groups are substituted at positions 3, 5, and 4' by hydroxy groups.
Chemical ID:
MESH:C059514
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of GSK3B protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein]; [Resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased phosphorylation of and results in decreased localization of CTNNB1 protein; [Resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSF1 mRNA; [Resveratrol results in decreased phosphorylation of GSK3B protein] which results in decreased expression of HSPA1A protein; [Resveratrol results in increased activity of GSK3B protein] which results in decreased expression of HSF1 mRNA; [Resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein] which results in decreased phosphorylation of and results in increased localization of CTNNB1 protein; ARRB2 protein affects the reaction [Resveratrol results in decreased expression of GSK3B protein modified form]; dorsomorphin inhibits the reaction [Resveratrol results in decreased activity of GSK3B protein]; dorsomorphin inhibits the reaction [Resveratrol results in increased phosphorylation of GSK3B protein]; GSK3B protein affects the reaction [Resveratrol results in increased expression of FTH1 mRNA]; Okadaic Acid inhibits the reaction [Resveratrol results in decreased phosphorylation of GSK3B protein]; Resveratrol inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein]; Resveratrol inhibits the reaction [GSK3B protein binds to SIRT1 protein]; Resveratrol inhibits the reaction [MFGE8 protein results in decreased expression of GSK3B protein modified form]; Resveratrol results in decreased phosphorylation of and results in decreased activity of GSK3B protein; Resveratrol results in increased phosphorylation of and results in increased activity of GSK3B protein
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased activity of GSK3B protein]; [resveratrol results in increased activity of GSK3B protein] which results in increased phosphorylation of VASP protein; resveratrol inhibits the reaction [APP protein modified form results in decreased expression of GSK3B protein modified form]; resveratrol inhibits the reaction [Excitatory Amino Acid Agonists affects the phosphorylation of GSK3B protein]; resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein; resveratrol results in increased phosphorylation of and results in increased localization of and results in increased activity of GSK3B protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein]; [Resveratrol co-treated with Excitatory Amino Acid Agents] results in increased phosphorylation of and results in decreased activity of GSK3B protein; [Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose; dorsomorphin inhibits the reaction [[Resveratrol results in increased phosphorylation of GSK3B protein] which results in increased uptake of Glucose]; Resveratrol inhibits the reaction [Dietary Fats results in increased expression of GSK3B mRNA]; Resveratrol results in increased phosphorylation of and results in decreased activity of GSK3B protein
